Santen granted rights to develop and market lomerizine for ophthalmological indications Feb. 27, 2001 No Comments
New ROCK inhibitor with potential for the treatment of glaucoma licensed out by Welfide Jan. 25, 2001 No Comments
Allergan obtains rights to compound for PDT of age-related macular degeneration Jan. 19, 2001 No Comments
RSS